Invesco
AXDX

Invesco’s Accelerate Diagnostics AXDX Stock Holding History

Invesco’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,372
Closed -$19K – 4047
2022
Q1 		$19K Sell
1,372
-24
-2% -$683 ﹤0.01% 3989
2021
Q4 		$72K Sell
1,396
-39
-3% -$2.17K ﹤0.01% 3938
2021
Q3 		$85K Buy
1,435
+292
+26% +$19K ﹤0.01% 3960
2021
Q2 		$92K Buy
+1,143
New +$90.9K ﹤0.01% 3903
2019
Q2 		– Sell
-1,564
Closed -$329K – 3720
2019
Q1 		$329K Buy
1,564
+151
+11% +$28.3K ﹤0.01% 3458
2018
Q4 		$162K Sell
1,413
-301
-18% -$44.6K ﹤0.01% 3593
2018
Q3 		$393K Buy
1,714
+434
+34% +$96K ﹤0.01% 3525
2018
Q2 		$285K Buy
+1,280
New +$286K ﹤0.01% 3612
2017
Q4 		– Sell
-2,884
Closed -$647K – 3640
2017
Q3 		$647K Buy
+2,884
New +$708K ﹤0.01% 3212
2017
Q1 		– Sell
-5,795
Closed -$1.2M – 3697
2016
Q4 		$1.2M Buy
+5,795
New +$1.38M ﹤0.01% 2900
2015
Q3 		– Sell
-20
Closed -$5K – 3802
2015
Q2 		$5K Buy
+20
New +$4.78K ﹤0.01% 4188
2014
Q2 		– Sell
-58,061
Closed -$12.7M – 4066
2014
Q1 		$12.7M Buy
+58,061
New +$8.6M 0.01% 1393
2013
Q4 		– Sell
-40,554
Closed -$5.44M – 4329
2013
Q3 		$5.44M Buy
+40,554
New +$3.62M ﹤0.01% 1864

Other funds holding AXDX

GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $214M AUM 45.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return

Invesco's AXDX Position: Q2 2022 in Review

Invesco sold out of Accelerate Diagnostics (AXDX) in Q2 2022, closing a stake of 1,372 shares — an estimated $19K sold.

Invesco first reported a position in AXDX in Q3 2013 and held it in 13 quarters. The position peaked at $12.7M in Q1 2014. 74 funds tracked by Wall St. Rank hold AXDX as of Q2 2022.

  • Invesco reported no remaining Accelerate Diagnostics position as of Q2 2022 after selling out during the quarter.
  • Invesco sold 1,372 Accelerate Diagnostics shares in Q2 2022, an estimated $19K.
  • Invesco first reported a position in Accelerate Diagnostics in Q3 2013 and held it in 13 quarters.
  • Invesco's Accelerate Diagnostics position peaked at $12.7M in Q1 2014.
  • 74 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2022.

Based on Invesco's 13F filing for Q2 2022, filed 15 Aug 2022.